Ian Walker
Keine laufenden Positionen mehr
Profil
Ian Walker worked as a Program Director at Quadrant Healthcare Plc, a Development Pharmacist at Reckitt & Colman Plc, Head of Technical Services at Ethical Pharmaceuticals Ltd., Head of Development Group at Sosei R&D Ltd., and as a Project Head at Acacia Pharma Ltd.
He also worked at Deloitte Touche Tohmatsu Services LLC.
Ehemalige bekannte Positionen von Ian Walker
| Unternehmen | Position | Ende |
|---|---|---|
Quadrant Healthcare Plc
 Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Corporate Officer/Principal | - |
Ethical Pharmaceuticals Ltd.
 Ethical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Ethical Pharmaceuticals Ltd. is a British company that provides research and development services into new drug delivery systems and pharmaceutical products. The company is based in Ely, UK. Ethical Pharmaceuticals was acquired by Sanofi on September 01, 1994 for $140.35 million. | Technik-/Wissenschafts-/F&E-Leiter | - |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Corporate Officer/Principal | - |
| Reckitt & Colman Plc | Corporate Officer/Principal | - |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
| Reckitt & Colman Plc | Commercial Services |
Quadrant Healthcare Plc
Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Health Technology |
Ethical Pharmaceuticals Ltd.
Ethical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Ethical Pharmaceuticals Ltd. is a British company that provides research and development services into new drug delivery systems and pharmaceutical products. The company is based in Ely, UK. Ethical Pharmaceuticals was acquired by Sanofi on September 01, 1994 for $140.35 million. | Health Technology |
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Health Technology |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
